Logo image of NOM

NUVEEN MO QLTY MUNI INC (NOM) Stock Price, Quote, News and Overview

NYSE:NOM - New York Stock Exchange, Inc. - US67060Q1085 - Currency: USD

11.23  +0.39 (+3.6%)

Fundamental Rating

1

Overall NOM gets a fundamental rating of 1 out of 10. We evaluated NOM against 0 industry peers in the Unkown industry. NOM may be in some trouble as it scores bad on both profitability and health. NOM has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

NOM had positive earnings in the past year.
In the past year NOM has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: NOM reported negative net income in multiple years.
Of the past 5 years NOM 4 years had a positive operating cash flow.
NOM Yearly Net Income VS EBIT VS OCF VS FCFNOM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M

1.2 Ratios

Industry RankSector Rank
ROA -2.61%
ROE -4.46%
ROIC 1.5%
ROA(3y)-1.37%
ROA(5y)0.23%
ROE(3y)-2.54%
ROE(5y)0.17%
ROIC(3y)1.8%
ROIC(5y)1.82%
NOM Yearly ROA, ROE, ROICNOM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 -10

1.3 Margins

NOM's Operating Margin has declined in the last couple of years.
In the last couple of years the Gross Margin of NOM has declined.
Industry RankSector Rank
OM 45.99%
PM (TTM) N/A
GM 47.59%
OM growth 3Y-7.18%
OM growth 5Y-5.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.06%
GM growth 5Y-5.84%
NOM Yearly Profit, Operating, Gross MarginsNOM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 100 -100 -150

More info and screens

0

2. Health

2.1 Basic Checks

NOM has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for NOM has been increased compared to 5 years ago.
The debt/assets ratio for NOM is higher compared to a year ago.
NOM Yearly Shares OutstandingNOM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M 2M
NOM Yearly Total Debt VS Total AssetsNOM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

NOM has an Altman-Z score of 1.70. This is a bad value and indicates that NOM is not financially healthy and even has some risk of bankruptcy.
NOM has a Debt/Equity ratio of 0.68. This is a neutral value indicating NOM is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Altman-Z 1.7
ROIC/WACCN/A
WACCN/A
NOM Yearly LT Debt VS Equity VS FCFNOM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 0.17 indicates that NOM may have some problems paying its short term obligations.
A Quick Ratio of 0.17 indicates that NOM may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.17
Quick Ratio 0.17
NOM Yearly Current Assets VS Current LiabilitesNOM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M 2M

More info and screens

1

3. Growth

3.1 Past

NOM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 117.69%, which is quite impressive.
NOM shows a small growth in Revenue. In the last year, the Revenue has grown by 5.74%.
Measured over the past years, NOM shows a decrease in Revenue. The Revenue has been decreasing by -2.86% on average per year.
EPS 1Y (TTM)117.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%138.23%
Revenue 1Y (TTM)5.74%
Revenue growth 3Y-2.87%
Revenue growth 5Y-2.86%
Sales Q2Q%4.78%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NOM Yearly Revenue VS EstimatesNOM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M 2M
NOM Yearly EPS VS EstimatesNOM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 31.19, which means the current valuation is very expensive for NOM.
The average S&P500 Price/Earnings ratio is at 30.42. NOM is around the same levels.
Industry RankSector Rank
PE 31.19
Fwd PE N/A
NOM Price Earnings VS Forward Price EarningsNOM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NOM Per share dataNOM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.01%, NOM is a good candidate for dividend investing.
NOM's Dividend Yield is rather good when compared to the S&P500 average which is at 2.30.
Industry RankSector Rank
Dividend Yield 6.01%

5.2 History

The dividend of NOM decreases each year by -8.85%.
NOM has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of NOM decreased recently.
Dividend Growth(5Y)-8.85%
Div Incr Years1
Div Non Decr Years1
NOM Yearly Dividends per shareNOM Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

NOM has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-75.83%
EPS Next 2YN/A
EPS Next 3YN/A
NOM Yearly Income VS Free CF VS DividendNOM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M

More info and screens

NUVEEN MO QLTY MUNI INC

NYSE:NOM (2/20/2025, 2:51:45 PM)

11.23

+0.39 (+3.6%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners17.79%
Inst Owner Change2.64%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap26.39M
Analysts0
Price TargetN/A
Short Float %0.19%
Short Ratio0.66
Dividend
Industry RankSector Rank
Dividend Yield 6.01%
Yearly Dividend0.39
Dividend Growth(5Y)-8.85%
DP-75.83%
Div Incr Years1
Div Non Decr Years1
Ex-Date02-14 2025-02-14 (0.0675)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 31.19
Fwd PE N/A
P/S 14.11
P/FCF N/A
P/OCF N/A
P/B 0.98
P/tB 0.98
EV/EBITDA N/A
EPS(TTM)0.36
EY3.21%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS0.8
BVpS11.46
TBVpS11.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.61%
ROE -4.46%
ROCE 1.9%
ROIC 1.5%
ROICexc 1.5%
ROICexgc 1.5%
OM 45.99%
PM (TTM) N/A
GM 47.59%
FCFM N/A
ROA(3y)-1.37%
ROA(5y)0.23%
ROE(3y)-2.54%
ROE(5y)0.17%
ROIC(3y)1.8%
ROIC(5y)1.82%
ROICexc(3y)1.81%
ROICexc(5y)1.83%
ROICexgc(3y)1.81%
ROICexgc(5y)1.83%
ROCE(3y)2.27%
ROCE(5y)2.3%
ROICexcg growth 3Y-6.74%
ROICexcg growth 5Y-6.92%
ROICexc growth 3Y-6.74%
ROICexc growth 5Y-6.92%
OM growth 3Y-7.18%
OM growth 5Y-5.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.06%
GM growth 5Y-5.84%
F-Score3
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.43
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.17
Quick Ratio 0.17
Altman-Z 1.7
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)117.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%138.23%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.74%
Revenue growth 3Y-2.87%
Revenue growth 5Y-2.86%
Sales Q2Q%4.78%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-25.86%
EBIT growth 3Y-9.85%
EBIT growth 5Y-8.56%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-111.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-111.68%
OCF growth 3YN/A
OCF growth 5YN/A